Redmile Group

Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics | Globe Newswire | 7/1/2020

… biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye, today announced the closing of a $100 million financing led by new investor Redmile Group . Additional new investors included funds and accounts managed by BlackRock, Deerfield Management Company, Eventide Asset Management, Farallon Capital Management, Janus Henderson Investors and Logos Capital, who were joined by existing investors Adage Capital Partners …

Optimal Asset Management Inc. Acquires 3,672 Shares of DexCom, Inc. (NASDAQ:DXCM) | 6/27/2020

… DexCom by 8.7% during the 1st quarter. APG Asset Management N.V. now owns 129,388 shares of the medical device company’s stock valued at $34,840,000 after buying an additional 10,319 shares during the period. Finally, Redmile Group LLC bought a new position in shares of DexCom during the 1st quarter valued at $34,817,000. 97.08% of the stock is currently owned by hedge funds and other institutional investors. Get DexCom alerts: Shares …

Follow Redmile Group:    

Johnson Investment Counsel Inc. Has $1.02 Million Stock Holdings in Catalent Inc (NYSE:CTLT) | 6/25/2020

… Catalent were worth $1,020,000 as of its most recent filing with the Securities and Exchange Commission. Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Redmile Group LLC acquired a new stake in shares of Catalent during the 1st quarter worth approximately $26,302,000. Townsquare Capital LLC boosted its position in shares of Catalent by 69.7% during the 1st quarter. Townsquare Capital …

Yumanity and Merck Ink $500 Million+ Deal for Neurodegenerative Diseases | 6/24/2020

… milestone payments totaling about $500 million in addition to royalties on net sales. Merck is also joining existing Yumanity investors in a Series C financing round. The existing investors include Fidelity Management & Research Company, Redmile Group , Pfizer Ventures, Alexandria Venture Investments, Tony Coles, and Dolby Family Ventures. ad “We are excited to collaborate with the Merck neuroscience team focused on the goal of bringing novel therapeutic options to ALS and …

Yumanity and Merck Ink Deal for Neurodegenerative Diseases | 6/24/2020

… milestone payments totaling about $500 million in addition to royalties on net sales. Merck is also joining existing Yumanity investors in a Series C financing round. The existing investors include Fidelity Management & Research Company, Redmile Group , Pfizer Ventures, Alexandria Venture Investments, Tony Coles, and Dolby Family Ventures. “We are excited to collaborate with the Merck neuroscience team focused on the goal of bringing novel therapeutic options to ALS and FTLD …

Redmile Group LLC Has $12.07 Million Stock Holdings in Akero Therapeutics (NASDAQ:AKRO) - TheOlympiaReport | 6/23/2020

Redmile Group LLC lessened its holdings in shares of Akero Therapeutics (NASDAQ:AKRO) by 51.1% in the first quarter, Holdings Channel.com reports. The fund owned 569,513 shares of the company’s stock after selling 594,489 shares during the quarter. Redmile Group LLC’s holdings in Akero Therapeutics were worth $12,074,000 at the end of the most recent quarter. Other institutional investors and hedge funds have also added to or reduced their stakes …

Redmile Group LLC Purchases New Shares in PPD (NASDAQ:PPD) - TheOlympiaReport | 6/23/2020

Redmile Group LLC purchased a new stake in shares of PPD (NASDAQ:PPD) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,290,832 shares of the company’s stock, valued at approximately $22,990,000. Several and hedge funds have also recently added to or reduced their stakes in the stock. Zimmer Partners LP purchased a new position in shares of PPD …

Prestige Wealth Management Group LLC Reduces Holdings in Merck & Co., Inc. (NYSE:MRK) - TheOlympiaReport | 6/23/2020

… Wealth Management Group LLC’s holdings in Merck & Co., Inc. were worth $2,367,000 as of its most recent SEC filing. Several other institutional investors and hedge funds have also modified their holdings of the company. Redmile Group LLC purchased a new stake in Merck & Co., Inc. in the 1st quarter worth approximately $60,667,000. Mercer Global Advisors Inc. ADV grew its stake in Merck & Co., Inc. by 55.7% in the 1st quarter …

Redmile Group LLC Makes New Investment in DexCom, Inc. (NASDAQ:DXCM) - TheOlympiaReport | 6/23/2020

… NASDAQ:DXCM) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 129,300 shares of the medical device company’s stock, valued at approximately $34,817,000. Redmile Group LLC owned approximately 0.14% of DexCom at the end of the most recent reporting period. Several other institutional investors have also made changes to their positions in the business. Baillie Gifford & Co. increased its …

Port Capital LLC Reduces Position in Merck & Co., Inc. (NYSE:MRK) | 6/23/2020

… LLC’s holdings in Merck & Co., Inc. were worth $962,000 as of its most recent SEC filing. Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Redmile Group LLC acquired a new position in shares of Merck & Co., Inc. in the first quarter valued at approximately $60,667,000. Mercer Global Advisors Inc. ADV increased its stake in Merck & Co., Inc. by 55.7% in …

Redmile Group LLC Invests $7.36 Million in Itamar Medical Ltd. (NASDAQ:ITMR) | 6/22/2020

… ITMR) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 625,000 shares of the company’s stock, valued at approximately $7,363,000. Redmile Group LLC owned about 5.60% of Itamar Medical as of its most recent filing with the Securities & Exchange Commission. Other hedge funds also recently bought and sold shares of the company. Royce & Associates LP acquired …

GlycoMimetics Inc (NASDAQ:GLYC) Shares Sold by Redmile Group LLC | 6/22/2020

… by 81.1% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 253,516 shares of the biotechnology company’s stock after selling 1,090,329 shares during the quarter. Redmile Group LLC owned approximately 0.58% of GlycoMimetics worth $578,000 at the end of the most recent quarter. Several other hedge funds and other institutional investors also recently modified their holdings of GLYC. SG Americas Securities …

Redmile Group LLC Takes $3.90 Million Position in Profound Medicl (NYSE:PROF) | 6/22/2020

Redmile Group LLC bought a new stake in shares of Profound Medicl (NYSE:PROF) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 400,000 shares of the company’s stock, valued at approximately $3,896,000. Redmile Group LLC owned 2.49% of Profound Medicl as of its most recent filing with the Securities and Exchange Commission. Other large investors also recently added …

Redmile Group LLC Sells 934,539 Shares of Vapotherm Inc (NYSE:VAPO) | 6/22/2020

… 97.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,000 shares of the company’s stock after selling 934,539 shares during the period. Redmile Group LLC owned approximately 0.12% of Vapotherm worth $471,000 as of its most recent SEC filing. Several other institutional investors and hedge funds also recently made changes to their positions in the company. Broadfin Capital …

Redmile Group LLC Sells 11,300 Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) | 6/22/2020

… 2.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 414,400 shares of the company’s stock after selling 11,300 shares during the period. Redmile Group LLC owned about 0.33% of Adaptive Biotechnologies worth $11,512,000 as of its most recent filing with the Securities and Exchange Commission. Several other institutional investors have also added to or reduced their stakes in …

Redmile Group LLC Takes $6.65 Million Position in Bill.com Holdings (NASDAQ:RVMD) | 6/22/2020

… stake in Bill.com Holdings (NASDAQ:RVMD) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 303,371 shares of the company’s stock, valued at approximately $6,647,000. Redmile Group LLC owned approximately 0.51% of Bill.com as of its most recent filing with the Securities & Exchange Commission. Several other hedge funds and other institutional investors also recently made changes to their positions in RVMD …

Redmile Group LLC Sells 65,981 Shares of Stereotaxis Inc (OTCMKTS:STXS) | 6/22/2020

… according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,103,327 shares of the medical equipment provider’s stock after selling 65,981 shares during the quarter. Redmile Group LLC owned 4.49% of Stereotaxis worth $9,372,000 as of its most recent SEC filing. Several other hedge funds have also recently added to or reduced their stakes in the stock. Tower Research Capital LLC …

Redmile Group LLC Sells 30,011 Shares of Hookipa Pharma Inc (NASDAQ:HOOK) | 6/22/2020

… 1.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,862,510 shares of the company’s stock after selling 30,011 shares during the period. Redmile Group LLC owned about 8.53% of Hookipa Pharma worth $15,366,000 as of its most recent filing with the Securities and Exchange Commission. Other institutional investors have also added to or reduced their stakes in the …

Redmile Group LLC Has $18.51 Million Stock Holdings in Shockwave Medical Inc (NASDAQ:SWAV) | 6/22/2020

… 1.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 557,800 shares of the company’s stock after selling 10,100 shares during the period. Redmile Group LLC owned about 1.75% of Shockwave Medical worth $18,508,000 as of its most recent filing with the Securities and Exchange Commission. Other institutional investors have also added to or reduced their stakes in the …

Ardelyx Inc (NASDAQ:ARDX) Shares Sold by Redmile Group LLC | 6/22/2020

… in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,904,100 shares of the biopharmaceutical company’s stock after selling 95,900 shares during the quarter. Redmile Group LLC owned 4.39% of Ardelyx worth $22,195,000 as of its most recent SEC filing. Several other institutional investors have also recently added to or reduced their stakes in ARDX. Ameritas Investment Partners Inc. lifted …

Redmile Group LLC Sells 38,400 Shares of Krystal Biotech Inc (NASDAQ:KRYS) | 6/22/2020

… first quarter, according to its most recent filing with the SEC. The institutional investor owned 1,051,800 shares of the company’s stock after selling 38,400 shares during the period. Krystal Biotech comprises approximately 1.3% of Redmile Group LLC’s portfolio, making the stock its 28th biggest position. Redmile Group LLC owned about 0.06% of Krystal Biotech worth $45,480,000 as of its most recent SEC filing. Other institutional investors and hedge funds also …

Wave Life Sciences Ltd (NASDAQ:WVE) Stock Position Decreased by Redmile Group LLC | 6/22/2020

… in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,927,352 shares of the company’s stock after selling 399,141 shares during the period. Redmile Group LLC owned 8.39% of Wave Life Sciences worth $27,429,000 at the end of the most recent reporting period. Several other large investors have also made changes to their positions in the stock. BNP Paribas …

Redmile Group LLC Has $53.26 Million Position in Cigna Corp (NYSE:CI) | 6/22/2020

… 103.8% during the first quarter, Holdings Channel.com reports. The firm owned 300,600 shares of the health services provider’s stock after acquiring an additional 153,100 shares during the period. Cigna accounts for about 1.5% of Redmile Group LLC’s portfolio, making the stock its 23rd largest position. Redmile Group LLC’s holdings in Cigna were worth $53,260,000 at the end of the most recent reporting period. Other institutional investors have also bought and …

Redmile Group LLC Buys Shares of 788,500 Merck & Co., Inc. (NYSE:MRK) | 6/22/2020

… company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 788,500 shares of the company’s stock, valued at approximately $60,667,000. Merck & Co., Inc. makes up about 1.7% of Redmile Group LLC’s investment portfolio, making the stock its 16th largest position. Several other hedge funds and other institutional investors have also made changes to their positions in MRK. BerganKDV Wealth Management LLC increased its position …

Redmile Group LLC Has $53.89 Million Position in Novartis AG (NYSE:NVS) | 6/22/2020

… in its most recent Form 13F filing with the SEC. The institutional investor owned 653,600 shares of the company’s stock after purchasing an additional 80,500 shares during the quarter. Novartis comprises about 1.5% of Redmile Group LLC’s investment portfolio, making the stock its 22nd largest position. Redmile Group LLC’s holdings in Novartis were worth $53,889,000 at the end of the most recent quarter. A number of other institutional investors have …

COVID-19

Clear Labs Raises $18M; Plans to Expand Application of Automated Next-Generation Sequencing Platform to COVID-19 Diagnostics | 5/14/2020

Clear Labs Raises $18M; Plans to Expand Application of Automated Next-Generation Sequencing Platform to COVID-19 Diagnostics Share Article Company’s novel characterizing diagnostic could significantly improve testing rates, results, and ability to trace the … raise of a $18M strategic round of funding led by Redmile Group, as well as existing investors including Wing VC, Menlo Ventures, Tyson Ventures, Khosla Ventures, GV, Felicis Ventures, and HBM Genomics. To date, Clear …

Cell and gene therapy startup ElevateBio raises $170 million | 3/30/2020

… investors The Invus Group, Surveyor Capital, EDBI, and Vertex Ventures, along with existing investors F2 Ventures, MPM Capital, EcoR1 Capital, Redmile Group and Samsara BioCapital. ElevateBio, which was officially launched to the public less than … its efforts towards research focused on mitigating the impact of COVID-19; specifically, its AlloVir subsidiary has expanding an existing research agreement in place with the Baylor College of Medicine to work on developing a …

Regenerative Medicine

LifeSprout, Inc. Closes $28.5 Million Series A Financing | PR Newswire | 4/27/2020

BALTIMORE, Md. , April 27, LifeSprout, a privately-held regenerative medicine company founded with technology licensed from Johns Hopkins University , has closed a $28.5 million Series A financing. The company is using proceeds to support clinical development of novel therapeutic products from its Regenerative Matrix platform. The financing was led by Redmile Group, LLC, with new institutional investors Nexus Management, LP, Emerald Development Managers, LP, and the Abell Foundation joining the …

Audentes Therapeutics: Encouraging Progress In XLMTM, Pipeline Continues To Evolve - Audentes Therapeutics, Inc. (NASDAQ:BOLD) | Seeking Alpha | 5/28/2019

… as Duchenne Muscular Dystrophy. Select Recent Developments On January 31st, the company provided an update after receiving minutes from its Regenerative Medicine and Advanced Therapy/Type B meeting with the FDA held in December (concerning … Baker Brothers has been adding to its stake as have Redmile Group and BB Biotech. Great Point Partners and Orbimed Advisors also own decent-sized positions. A history of some insider selling is not encouraging …

Medical Documentation

Remote Medical Documentation Company Augmedix Closes $19 Million In Funding | 11/6/2019

Remote medical documentation company Augmedix announced that it raised $19 million in Series B funding from Redmile, McKesson, DCM, and Wanxiang Healthcare. Augmedix — a remote medical documentation company — announced recently that it raised $19 million in Series B funding. This round of funding includes investments from Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and several others. With this round of funding, Augmedix plans to use the funding to …

Health tech funding snapshot—Google joins $50M round in Viz.ai, Augmedix raises $19 million, and more | FierceHealthcare | 11/1/2019

… medical documentation: Tech-enabled remote documentation company Augmedix uses natural-language-processing technology and remote medical documentation experts to help reduce the burden of medical documentation for physicians. The San Francisco-based company landed $19 million in Series B funding that included investments from Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and others. Augmedix provides clinicians with hardware, smartphones or Google Glass, to stream the clinic visit to …

Digital Health

Health tech funding snapshot—Google joins $50M round in Viz.ai, Augmedix raises $19 million, and more | FierceHealthcare | 11/1/2019

… medical documentation for physicians. The San Francisco-based company landed $19 million in Series B funding that included investments from Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and others. Augmedix provides clinicians with … Serial entrepreneur Halle Tecco, the founder and former CEO of digital health investment fund Rock Health, launched Natalist in August. The Charleston, South Carolina-based startup raised $5 million from a host of angel investors …

Startup Call9 shutting down operations for telehealth services to nursing homes | FierceHealthcare | 6/26/2019

… venture capital but struggled to secure additional funds to scale its business and manage the high cost of running a digital healthcare firm, reports CNBC’s Chrissy Farr. Call9 , founded in Silicon Valley and then headquartered … there,” Peck said, according to CNBC. Investors in Call9 included Redmile Group, Index Ventures, Refactor Capital and Y Combinator …

Biotech

David Hung and ex-Medivation execs join forces for stealthy cancer startup | FierceBiotech | 10/28/2019

… the Tavistock Group, EDBI (a global Asia-based investor), ECOR1 Capital, Fidelity Management and Research Company, Pavilion Capital, Perceptive Advisors, Redmile Group, Surveyor Capital (a Citadel company) and other institutional investors. Survey Industry Insight Survey … time of it than he did at Vivek Ramaswamy’s Axovant biotech, which saw big raises and an IPO based on the hopes of some old Alzheimer’s disease therapies that turned out to be duds. Hung …

Hung, ex-Medivation execs join forces for stealthy cancer startup | FierceBiotech | 10/28/2019

… the Tavistock Group, EDBI (a global Asia-based investor), ECOR1 Capital, Fidelity Management and Research Company, Pavilion Capital, Perceptive Advisors, Redmile Group, Surveyor Capital (a Citadel company) and other institutional investors. Take the Survey As … time of it than he did at Vivek Ramaswamy’s Axovant biotech, which saw big raises and an IPO based on the hopes of some old Alzheimer’s disease therapies that turned out to be duds. Hung …

HIPAA

Augmedix Raises $19M To Streamline Physician Services With Automated Note-Taking – Crunchbase News | 10/24/2019

… documentation startup, announced today it has raised $19 million in a Series B round to help it achieve its mission. Redmile Group , McKesson Ventures , DCM Ventures , Wanxiang Healthcare Investments and others participated in the financing … earnest,” the CEO added. I asked if the company was HIPAA compliant and it told me that its entire system satisfies HIPAA data security standards. Illustration: Li-Anne Dias Tags health tech …

Startup Call9 shutting down operations for telehealth services to nursing homes | FierceHealthcare | 6/26/2019

… care coordination business, discontinued operations last June. CloudMine, a company that offered the ability to build digital apps through a HIPAA-compliant cloud-based healthcare platform, filed for Chapter 7 bankruptcy in November. Peck told … there,” Peck said, according to CNBC. Investors in Call9 included Redmile Group, Index Ventures, Refactor Capital and Y Combinator …

Medical Research

-$0.04 Earnings Per Share Expected for Heska Corp (NASDAQ:HSKA) This Quarter - TheOlympiaReport | 10/18/2019

… firms that follow Heska. Get Heska alerts: Heska (NASDAQ:HSKA) last released its earnings results on Tuesday, August 6th. The medical research company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.07 … after acquiring an additional 10,521 shares in the last quarter. Redmile Group LLC lifted its position in shares of Heska by 14.3% in the first quarter. Redmile Group LLC now owns 226,013 shares of the …

Heska Corp (NASDAQ:HSKA) Expected to Post Quarterly Sales of $30.44 Million - Ticker Report | 10/15/2019

… that follow Heska. Get Heska alerts: Heska (NASDAQ:HSKA) last issued its quarterly earnings results on Tuesday, August 6th. The medical research company reported ($0.03) earnings per share (EPS) for the quarter, topping the Thomson … after purchasing an additional 5,019 shares in the last quarter. Redmile Group LLC lifted its holdings in shares of Heska by 14.3% in the first quarter. Redmile Group LLC now owns 226,013 shares of the …

Medicare

Startup Call9 shutting down operations for telehealth services to nursing homes | FierceHealthcare | 6/26/2019

Medicare and for the long-term health of startups. But we also know that fee for service can give you more revenue compensation in the short-term, and start-ups often feel that pressure to focus their efforts there,” Peck said, according to CNBC. Investors in Call9 included Redmile Group, Index Ventures, Refactor Capital and Y Combinator …

Startup Call9 shutting down operations for telehealth services to nursing homes | FierceHealthcare | 6/25/2019

Medicare and for the long-term health of startups. But we also know that fee for service can give you more revenue compensation in the short-term, and start-ups often feel that pressure to focus their efforts there,” Peck said, according to CNBC. Investors in Call9 included Redmile Group, Index Ventures, Refactor Capital and Y Combinator. Read more on …

Gene Therapy

Biotech builder ElevateBio reveals its first portfolio company: AlloVir | FierceBiotech | 5/22/2019

ElevateBio launched just last week with $150 million to build cell and gene therapy companies. Now, it’s unveiling its first portfolio company: AlloVir, a biotech working on off-the-shelf T-cell therapies against several … in series B financing from a slate of investors including Redmile Group, EcoR1 Capital and Samsara BioCapital, all of which backed ElevateBio’s series A. Fidelity Management and Research Company, Gilead Sciences, F2 Ventures, Invus and …

ElevateBio Announces that AlloVir Joins its Portfolio of Highly Innovative Cell and Gene Therapy Companies | Business Wire | 5/22/2019

CAMBRIDGE, Mass.- ElevateBio, a cell and gene therapy holding company, announced today that AlloVir, formerly known as ViraCyte, has joined its growing portfolio of highly innovative companies. AlloVir, a late-clinical stage allogeneic cell therapy … and Research Company, and joined by Gilead Sciences, F2 Ventures, Redmile Group, Invus, EcoR1 Capital, Samsara BioCapital, and Leerink Partners Co-investment Fund, LLC. AlloVir is leading the way in the clinical development of novel …

Celgene

ElevateBio Appoints Kareem Reda as Chief Business Officer | Business Wire | 3/5/2020

… IPO) and private Series B and C fundraising rounds, helping to raise over $200 million. Mr. Reda previously worked at Celgene in business development where he executed over a dozen deals with a total value … MPM Capital and F2 Ventures. Investors also include EcoR1 Capital, Redmile Group, and Samsara BioCapital. For more information, please visit www.elevate.bio View source version on businesswire.com : https://www.businesswire.com/news/home/20200305005798/en/ CONTACT: Courtney Heath …

Novartis

Targeting deadly lung-scarring disease, Peninsula biotech snares $100M crossover round | The Business Journals | 3/3/2020

… that builds up and blocks the lungs and bile ducts, Pliant Therapeutics Inc. raised a $100 million round from giant Novartis AG and a band of crossover investors that will launch its marquee drug through … drug maker Novartis AG, but was joined by crossover investors Redmile Group, Farallon Capital Management, Cormorant Asset Management, Surveyor Capital and Logos Capital, hinting that Pliant is lining up an initial public offering. Existing investors …

Wright Medical

$259.35 Million in Sales Expected for Wright Medical Group NV (NASDAQ:WMGI) This Quarter | Daily Political | 12/2/2019

Wall Street analysts expect that Wright Medical Group NV (NASDAQ:WMGI) will report sales of $259.35 million for the current fiscal quarter, according to Zacks Investment Research . Fifteen analysts have issued estimates for Wright Medical … after acquiring an additional 141,799 shares during the period. Finally, Redmile Group LLC lifted its holdings in Wright Medical Group by 1.3% in the third quarter. Redmile Group LLC now owns 2,404,157 shares of the …

McKesson

Augmedix Gets $19 million In Funding For Medical Transcribing Platform | 12/1/2019

Remote medical note documentation company Augmedix is primed to accelerate product development, such as automation capabilities, and to strategically scale its technology-enabled service across health systems and private clinics nationwide, following the closure of a Series B financing round, where it raised $19 million. The funding included investment from Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and other unnamed investors. Reducing physician burnout One of Augmedix’s goals …

AnaptysBio

Redmile Group LLC Boosts Stock Holdings in AnaptysBio Inc (NASDAQ:ANAB) | 11/29/2019

Redmile Group LLC Boosts Stock Holdings in AnaptysBio Inc (NASDAQ:ANAB) Posted by Kim Johansen on Nov 29th, 2019 // Comments off Redmile Group LLC boosted its stake in shares of AnaptysBio Inc (NASDAQ:ANAB) by 0.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 612,558 shares of the biotechnology company’s stock after purchasing an additional 2,900 shares …

Augmedix

Remote Medical Documentation Company Augmedix Closes $19 Million In Funding | 11/6/2019

Remote medical documentation company Augmedix announced that it raised $19 million in Series B funding from Redmile, McKesson, DCM, and Wanxiang Healthcare. Augmedix — a remote medical documentation company — announced recently that it raised $19 million in Series B funding. This round of funding includes investments from Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and several others. With this round of funding, Augmedix plans to use the funding to …

Epizyme

17,653 Shares in Epizyme Inc (NASDAQ:EPZM) Purchased by Man Group plc | 11/2/2019

Man Group plc purchased a new position in shares of Epizyme Inc (NASDAQ:EPZM) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 17,653 shares of the … 80,831,000 after purchasing an additional 1,552,216 shares during the period. Redmile Group LLC raised its stake in Epizyme by 15.9% during the first quarter. Redmile Group LLC now owns 7,694,020 shares of the biopharmaceutical company’s …

Pfizer

David Hung and ex-Medivation execs join forces for stealthy cancer startup | FierceBiotech | 10/28/2019

… David Hung, M.D., has had a strange few years: From the man who led Medivation to being snapped up by Pfizer in a major $14 billion M&A deal, he then went over to Axovant … Capital, Fidelity Management and Research Company, Pavilion Capital, Perceptive Advisors, Redmile Group, Surveyor Capital (a Citadel company) and other institutional investors. Survey Industry Insight Survey: Direct-to-Patient Distribution of Clinical Supplies This industry survey …

Medivation

David Hung and ex-Medivation execs join forces for stealthy cancer startup | FierceBiotech | 10/28/2019

David Hung, M.D., has had a strange few years: From the man who led Medivation to being snapped up by Pfizer in a major $14 billion M&A deal, he then went over to Axovant … Capital, Fidelity Management and Research Company, Pavilion Capital, Perceptive Advisors, Redmile Group, Surveyor Capital (a Citadel company) and other institutional investors. Survey Industry Insight Survey: Direct-to-Patient Distribution of Clinical Supplies This industry survey …

ImmunoGen

Morgan Stanley Purchases 2,493,037 Shares of ImmunoGen, Inc. (NASDAQ:IMGN) | 10/13/2019

Morgan Stanley Purchases 2,493,037 Shares of ImmunoGen, Inc. (NASDAQ:IMGN) Posted by John Braxton on Oct 13th, 2019 Tweet Morgan Stanley boosted its position in shares of ImmunoGen, Inc. (NASDAQ:IMGN) by 74.6% during the … hedge funds also recently modified their holdings of the business. Redmile Group LLC grew its stake in ImmunoGen by 20.0% in the 1st quarter. Redmile Group LLC now owns 13,063,767 shares of the biotechnology company’s …

Teva Pharmaceutical

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Shares Acquired by Nomura Asset Management Co. Ltd. | 10/11/2019

Nomura Asset Management Co. Ltd. boosted its position in shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) by 16.9% during the second quarter, according to the company in its most recent Form 13F filing with … after acquiring an additional 1,569,500 shares during the last quarter. Redmile Group LLC raised its holdings in shares of Teva Pharmaceutical Industries by 72.1% in the first quarter. Redmile Group LLC now owns 3,147,000 shares …

Teva Pharmaceutical

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Shares Acquired by Nomura Asset Management Co. Ltd. | 10/11/2019

Nomura Asset Management Co. Ltd. boosted its position in shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) by 16.9% during the second quarter, according to the company in its most recent Form 13F filing with … after acquiring an additional 1,569,500 shares during the last quarter. Redmile Group LLC raised its holdings in shares of Teva Pharmaceutical Industries by 72.1% in the first quarter. Redmile Group LLC now owns 3,147,000 shares …

MedImmune

IPO Update: Innate Pharma Readies Plan For U.S. IPO - Innate Pharma (Pending:IPHA) | Seeking Alpha | 10/7/2019

… CEO Mondher Mahjoubi , who has been with the firm since 2017 and was previously SVP Therapeutic Area Head-Oncology at MedImmune ( AZN ). Innate Pharma is targeting checkpoints expressed on Natural Killer [NK] cells and myeloid … registration statement Investors in Innate Pharma include AstraZeneca, QVT Financial, Redmile Group, Ardian, ACE Management, NIF SMBC Ventures, Novo Nordisk, Akka Venture, Sofinnova Partners, and Gimv among others. Source: Crunchbase Market & Competition According to a …

LivaNova

LivaNova PLC (NASDAQ:LIVN) Shares Sold by Allianz Asset Management GmbH | 10/6/2019

Allianz Asset Management GmbH reduced its holdings in LivaNova PLC (NASDAQ:LIVN) by 65.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission … after acquiring an additional 24,561 shares during the last quarter. Redmile Group LLC increased its position in shares of LivaNova by 13.1% during the first quarter. Redmile Group LLC now owns 582,687 shares of the …

Genentech

IPO Update: BioNTech Proposes U.S. IPO Terms - BioNTech (Pending:BNTX) | Seeking Alpha | 9/30/2019

Genentech ( ROG ) in a Phase 1a/1b trial for the treatment of patients with late stage advanced cancers, including patients that failed multiple lines of prior treatment. Below is the current status of the company’s drug development pipeline: Source: Company registration statement Investors in BioNTech have included Fidelity Management and Research, Platinum Asset Management, MiraeAsset Asset Management, Jebsen Capital, Invus, BVCF, Athena Capital, Redmile Group, Sanofi ( SNY ), and MIG among …

Align Technology

Align Technology, Inc. (NASDAQ:ALGN) Shares Bought by KBC Group NV | 9/1/2019

KBC Group NV grew its stake in shares of Align Technology, Inc. (NASDAQ:ALGN) by 11.4% in the second the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund … after acquiring an additional 201,508 shares during the last quarter. Redmile Group LLC acquired a new position in shares of Align Technology during the 1st quarter valued at about $40,716,000. Frontier Capital Management Co. LLC …

Call9

After shutdown, telemedicine company Call9’s founder plans a comeback | Modern Healthcare | 7/25/2019

Call9, which had raised $40 million in equity and debt financing since its founding in 2015, learned that the hard way last month, when the company announced it would shut down and lay off its … Medicare. Its $24 million Series B round in 2017 attracted Redmile Group, a San Francisco–based investment firm that had previously focused on biotech companies. ArchCare, which runs the Mary Manning Walsh Nursing Home on …

UnitedHealth

Redmile Group LLC Purchases 17,390 Shares of UnitedHealth Group Inc (NYSE:UNH) | 7/10/2019

Redmile Group LLC Purchases 17,390 Shares of UnitedHealth Group Inc (NYSE:UNH) Posted by Irma Garcia on Jul 10th, 2019 Redmile Group LLC increased its position in UnitedHealth Group Inc (NYSE:UNH) by 15.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 132,890 shares of the healthcare conglomerate’s stock after buying an additional 17,390 shares …

UnitedHealth Group

Redmile Group LLC Purchases 17,390 Shares of UnitedHealth Group Inc (NYSE:UNH) | 7/10/2019

Redmile Group LLC Purchases 17,390 Shares of UnitedHealth Group Inc (NYSE:UNH) Posted by Irma Garcia on Jul 10th, 2019 Redmile Group LLC increased its position in UnitedHealth Group Inc (NYSE:UNH) by 15.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 132,890 shares of the healthcare conglomerate’s stock after buying an additional 17,390 shares …

Teladoc

Redmile Group LLC Buys 244,300 Shares of Teladoc Health Inc (NYSE:TDOC) | 7/10/2019

Redmile Group LLC Buys 244,300 Shares of Teladoc Health Inc (NYSE:TDOC) Posted by Charles Blunt on Jul 9th, 2019 Redmile Group LLC grew its position in Teladoc Health Inc (NYSE:TDOC) by 124.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 439,900 shares of the health services provider’s stock after purchasing an additional 244,300 shares during the …

ICU Medical

Redmile Group LLC Has $12.38 Million Stock Holdings in ICU Medical, Incorporated (NASDAQ:ICUI) | 7/10/2019

Redmile Group LLC Has $12.38 Million Stock Holdings in ICU Medical, Incorporated (NASDAQ:ICUI) Posted by Denise Davis on Jul 9th, 2019 Redmile Group LLC trimmed its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 43.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 51,721 shares of the medical instruments supplier’s stock after selling 39,600 shares during the …

LogicBio Therapeutics

Redmile Group LLC Sells 1,500 Shares of LogicBio Therapeutics Inc (NASDAQ:LOGC) | 7/10/2019

Redmile Group LLC Sells 1,500 Shares of LogicBio Therapeutics Inc (NASDAQ:LOGC) Posted by Denise Davis on Jul 9th, 2019 Redmile Group LLC trimmed its stake in LogicBio Therapeutics Inc (NASDAQ:LOGC) by 0.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 909,787 shares of the company’s stock after selling 1,500 shares during the period. Redmile Group

AtriCure

Redmile Group LLC Has $8.71 Million Stock Holdings in AtriCure Inc. (NASDAQ:ATRC) | 7/10/2019

Redmile Group LLC Has $8.71 Million Stock Holdings in AtriCure Inc. (NASDAQ:ATRC) Posted by Ryan Black on Jul 9th, 2019 Tweet Redmile Group LLC grew its position in AtriCure Inc. (NASDAQ:ATRC) by 8.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 325,000 shares of the medical device company’s stock after purchasing an additional 25,000 shares during …

Boston Scientific

Saluda Medical raises US$75 million equity financing from Boston Scientific and Redmile Group | 7/2/2019

Saluda Medical has announced that it has secured US$75 million in equity financing from Boston Scientific and Redmile Group. The latter investment is set to fund the final stages of development through commercialisation of its Evoke ECAP-controlled, closed-loop spinal cord stimulation (SCS) system for the treatment of chronic intractable pain of the trunk and limbs. Evoke is designed to be the first closed-loop SCS system that …

Bristol-Myers

Bristol-Myers Squibb Co (NYSE:BMY) Shares Bought by Redmile Group LLC | 6/24/2019

Bristol-Myers Squibb Co (NYSE:BMY) Shares Bought by Redmile Group LLC Posted by Arthur Bond on Jun 24th, 2019 Tweet Redmile Group LLC boosted its holdings in Bristol-Myers Squibb Co (NYSE:BMY) by 87.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,599,700 shares of the biopharmaceutical company’s stock after purchasing an additional 745,000 …

Baylor College of Medicine

Cell and gene therapy startup ElevateBio raises $170 million | TechCrunch | 3/30/2020

… investors The Invus Group, Surveyor Capital, EDBI, and Vertex Ventures, along with existing investors F2 Ventures, MPM Capital, EcoR1 Capital, Redmile Group and Samsara BioCapital. ElevateBio, which was officially launched to the public less than … has expanding an existing research agreement in place with the Baylor College of Medicine to work on developing a type of T-cell therapy that can help protect patients with conditions that compromise their immune …

Cell and gene therapy startup ElevateBio raises $170 million | TechCrunch | 3/30/2020

… investors The Invus Group, Surveyor Capital, EDBI, and Vertex Ventures, along with existing investors F2 Ventures, MPM Capital, EcoR1 Capital, Redmile Group and Samsara BioCapital. ElevateBio, which was officially launched to the public less than … has expanding an existing research agreement in place with the Baylor College of Medicine to work on developing a type of T-cell therapy that can help protect patients with conditions that compromise their immune …

Sutter Health

Health tech funding snapshot—Google joins $50M round in Viz.ai, Augmedix raises $19 million, and more | FierceHealthcare | 11/1/2019

… Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and others. Augmedix provides clinicians with hardware, smartphones or Google Glass, to stream the clinic visit to a cloud-based platform. Fifteen national health systems, including Sutter Health, CommonSpirit Health, and US Oncology, currently partner with Augmedix. Clinical trial technology: Healthcare technology company SignalPath raised $18 million Series B funding led by existing investors with a total raise of capital to …

Augmedix’s device-based remote scribing system announces $19M Series B | MobiHealthNews | 10/25/2019

… processing (NLP) and devices to populate medical documentation from clinician-patient conversations, has raised $19 million in Series B funding. Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments and other unnamed investors all contributed … company now boasts partnerships with 15 major health systems including Sutter Health, CommonSpirit Health and US Oncology, according to the funding announcement. “Our service is differentiated because it operates in real-time and is enabled …

CommonSpirit Health

Health tech funding snapshot—Google joins $50M round in Viz.ai, Augmedix raises $19 million, and more | FierceHealthcare | 11/1/2019

… Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and others. Augmedix provides clinicians with hardware, smartphones or Google Glass, to stream the clinic visit to a cloud-based platform. Fifteen national health systems, including Sutter Health, CommonSpirit Health, and US Oncology, currently partner with Augmedix. Clinical trial technology: Healthcare technology company SignalPath raised $18 million Series B funding led by existing investors with a total raise of capital to …

Augmedix’s device-based remote scribing system announces $19M Series B | MobiHealthNews | 10/25/2019

… processing (NLP) and devices to populate medical documentation from clinician-patient conversations, has raised $19 million in Series B funding. Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments and other unnamed investors all contributed … boasts partnerships with 15 major health systems including Sutter Health, CommonSpirit Health and US Oncology, according to the funding announcement. “Our service is differentiated because it operates in real-time and is enabled by natural …

LHC Group

Redmile Group LLC Has $240,000 Stake in LHC Group, Inc. (NASDAQ:LHCG) | 7/10/2019

Redmile Group LLC lessened its stake in shares of LHC Group, Inc. (NASDAQ:LHCG) by 48.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,166 shares of the health services provider’s stock after selling 2,034 shares during the quarter. Redmile Group LLC’s holdings in LHC Group were worth $240,000 at the end of the …

Redmile Group LLC Cuts Stock Position in LHC Group, Inc. (NASDAQ:LHCG) | 7/2/2019

Redmile Group LLC Cuts Stock Position in LHC Group, Inc. (NASDAQ:LHCG) Posted by Charles Blunt on Jul 2nd, 2019 Redmile Group LLC reduced its position in LHC Group, Inc. (NASDAQ:LHCG) by 48.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,166 shares of the health services provider’s stock after selling 2,034 shares during the quarter. Redmile Group

Cigna

Redmile Group LLC Has $265,000 Position in Cigna Corp (NYSE:CI) | 7/10/2019

Redmile Group LLC Has $265,000 Position in Cigna Corp (NYSE:CI) Posted by Shanna Eddington on Jul 9th, 2019 Tweet Redmile Group LLC cut its stake in Cigna Corp (NYSE:CI) by 99.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,648 shares of the health services provider’s stock after selling 273,962 shares during …

Cigna Corp (NYSE:CI) Shares Sold by Redmile Group LLC | 7/2/2019

Redmile Group LLC trimmed its position in shares of Cigna Corp (NYSE:CI) by 99.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,648 shares of the health services provider’s stock after selling 273,962 shares during the period. Redmile Group LLC’s holdings in Cigna were worth $265,000 at the end of the most recent reporting period. Other hedge funds have …